Perez, Elviliza T.
HRN: 06-68-71 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/02/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/02/2024
03/09/2024
IV
1.5 Grams
Q6H
Wound Abscess, Left Axilla
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes